Back to Search

XUEREN ZHAO, MD

MD

Nuclear Medicine Physician

NPI: 1417180290IndividualAccepts Medicare

Specialties, Licenses & Credentials

Nuclear Cardiology Physician

Nuclear Medicine — Nuclear Cardiology

Code: 207UN0901X

A105851(CA)
Nuclear Imaging & Therapy Physician

Nuclear Medicine — Nuclear Imaging & Therapy

Code: 207UN0902X

A105851(CA)
In Vivo & In Vitro Nuclear Medicine Physician

Nuclear Medicine — In Vivo & In Vitro Nuclear Medicine

Code: 207UN0903X

A105851(CA)
Nuclear Radiology Physician

Radiology — Nuclear Radiology

Code: 2085N0904X

A105851(CA)
Nuclear Medicine PhysicianPrimary

Nuclear Medicine

Code: 207U00000X

A105851(CA)

CMS Specialties

PrimaryNUCLEAR MEDICINE

Education

OTHER

Class of 1986

Clinical Trials (2)

2
Linked Trials
0
Recruiting
2
With Results

Effects of SGLT-2 Inhibition on Myocardial Fibrosis and Inflammation as Assessed by Cardiac MRI in Patients With DM2

NCT03782259COMPLETEDPHASE4PRINCIPAL_INVESTIGATOR

Evaluate Carotid Artery Plaque Composition by Magnetic Resonance Imaging in People Receiving Cholesterol Medication

NCT00715273COMPLETEDPHASE4PRINCIPAL_INVESTIGATOR

Research & Publications (20)

Dapagliflozin Reduces Systemic Inflammation in Patients with Type 2 Diabetes Without Known Heart Failure.
PMID 38585865·Res Sq·2024
8-other
Dapagliflozin reduces systemic inflammation in patients with type 2 diabetes without known heart failure.
PMID 38849829·Cardiovasc Diabetol·2024
2-rct
Niacin Increases Atherogenic Proteins in High-Density Lipoprotein of Statin-Treated Subjects.
PMID 34134520·Arterioscler Thromb Vasc Biol·2021
3-trial
Metabolic and inflammatory risk reduction in response to lipid-lowering and lifestyle modification in the medically underserved individuals.
PMID 34401861·Am J Prev Cardiol·2021
8-other
High-resolution MRI assessed carotid atherosclerotic plaque characteristics comparing men and women with elevated ApoB levels.
PMID 32020410·Int J Cardiovasc Imaging·2020
4-observational
Niacin Therapy Increases High-Density Lipoprotein Particles and Total Cholesterol Efflux Capacity But Not ABCA1-Specific Cholesterol Efflux in Statin-Treated Subjects.
PMID 26681752·Arterioscler Thromb Vasc Biol·2016
4-observational
Imaging to Assess the Effect of Anti-Inflammatory Therapy in Aortic and Carotid Atherosclerosis.
PMID 27737745·J Am Coll Cardiol·2016
8-other
Effects of niacin on glucose levels, coronary stenosis progression, and clinical events in subjects with normal baseline glucose levels (<100 mg/dl): a combined analysis of the Familial Atherosclerosis Treatment Study (FATS), HDL-Atherosclerosis Treatment Study (HATS), Armed Forces Regression Study (AFREGS), and Carotid Plaque Composition by MRI during lipid-lowering (CPC) study.
PMID 23168285·Am J Cardiol·2013
4-observational
Carotid artery atherosclerosis: effect of intensive lipid therapy on the vasa vasorum--evaluation by using dynamic contrast-enhanced MR imaging.
PMID 21493792·Radiology·2011
2-rct
MR imaging of carotid plaque composition during lipid-lowering therapy a prospective assessment of effect and time course.
PMID 21920335·JACC Cardiovasc Imaging·2011
4-observational
Contrast-enhanced MRI of carotid atherosclerosis: dependence on contrast agent.
PMID 19557844·J Magn Reson Imaging·2009
3-trial
Combined statin and niacin therapy remodels the high-density lipoprotein proteome.
PMID 18765395·Circulation·2008
4-observational
Testing the hypothesis of atherosclerotic plaque lipid depletion during lipid therapy by magnetic resonance imaging: study design of Carotid Plaque Composition Study.
PMID 17643572·Am Heart J·2007
2-rct
Effects of adding extended-release niacin and colesevelam to statin therapy on lipid levels in subjects with atherosclerotic disease.
PMID 21291704·J Clin Lipidol·2007
8-other
Cyclic GMP-dependent protein kinase regulates CCAAT enhancer-binding protein beta functions through inhibition of glycogen synthase kinase-3.
PMID 16055922·J Biol Chem·2005
7-preclinical
Microwave pretreatment of substrates for cellulase production by solid-state fermentation.
PMID 19452284·Appl Biochem Biotechnol·2010
8-other
Targeting C-type lectin-like molecule-1 for antibody-mediated immunotherapy in acute myeloid leukemia.
PMID 19648166·Haematologica·2010
4-observational
Increased serum interleukin 17 in patients with systemic lupus erythematosus.
PMID 19347604·Mol Biol Rep·2010
8-other
Determination of curcumol in rat plasma by capillary gas chromatography with a hydrogen flame ionization detector.
PMID 19650148·Biomed Chromatogr·2010
7-preclinical
Greatly increased fiber transmission distance with an optically injection-locked vertical-cavity surface-emitting laser.
PMID 19654785·Opt Express·2009
8-other

Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.

Contact & Hours

Via practice · 6 locations total

Address
9400 CAMPUS POINT DR
LA JOLLA, CA 92093

Locations (6)

Practice Location

9400 CAMPUS POINT DR, LA JOLLA, CA
(800) 926-8273

Practice Location

9300 CAMPUS POINT DR, LA JOLLA, CA
(800) 926-8273

Practice Location

3270 Sawtelle Blvd Apt 304, Los Angeles, CA
(310) 997-0082

Practice Location

200 W ARBOR DR, SAN DIEGO, CA
(800) 926-8273

Practice Location

330 LEWIS ST, SAN DIEGO, CA
(800) 926-8273

Practice Location

6655 ALVARADO RD, SAN DIEGO, CA
(800) 926-8273

Quick Facts

NPI
1417180290
Entity Type
Individual
Gender
Male
Medicare
Accepted
Specialties
5
Locations
6
Years in Practice
40
Clinical Trials
2
Publications
20

Are you this provider?

Claim Your Profile